ARTICLE | Clinical News
Pradaxa regulatory update
August 8, 2011 7:00 AM UTC
The European Commission approved Pradaxa dabigatran to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). The direct oral thrombin inhibitor is already approv...